Back to Results
First PageMeta Content
Histopathology / End point of clinical trials / Response Evaluation Criteria in Solid Tumors / Vismodegib / Medicine / Basal-cell carcinoma / Carcinoma


Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (BCC): 24-month update of the pivotal ERIVANCE BCC study A Sekulic,1 MR Migden,2 AE Oro,3 L Dirix,4 K Lewis,5 JD Hainsworth,6
Add to Reading List

Document Date: 2014-05-12 19:51:02


Open Document

File Size: 321,96 KB

Share Result on Facebook
UPDATE